16 Nov

MedMen’s Cannabis Factories

WRITTEN BY Mike Benson

MedMen’s factories

MedMen (MMNFF) has three cultivation and production factories in Florida, Nevada, and New York. A new cultivation and production factory is under construction in California. These factories focus on the commercialization of cannabis as well as research and development of new strains and cultivation techniques.

MedMen’s Cannabis Factories

The above chart shows the MedMen’s factories.

Project Mustang, Nevada

Project Mustang is a 30,000-square-foot cultivation factory and a 15,000-square-foot production factory in northern Nevada. The facility is spread on 4.27 acres of land and includes a high-tech Dutch hybrid greenhouse and SQF 2008–compliant, state-of-the-art production and extraction equipment. Cultivation started in the third quarter of 2018 while product sales began in the fourth quarter.

Utica, New York

This is a temporary factory operated to serve the medical marijuana patients through a vertical-integrated license. This temporary facility includes a 1,600-square-foot cultivation factory and an 800-square-foot production factory. The company plans to develop a 45,000-square-foot cultivation and production factory at the same place, using the same model as Project Mustang.

Eustis, Florida

MedMen completed the acquisition of a master license and related assets for this facility from Treadwell Simpson Partnership and affiliates on September 6. The company operates a temporary facility at Eustis, Florida, and is planning to develop a cultivation and production factory based on the Project Mustang model.

Desert Hot Springs, California

This facility is under construction and includes a 30,000-square-foot cultivation factory and a 15,000-square-foot production factory in the first phase of development. The facility is spread across ten acres of land and is to include a high-tech Dutch hybrid greenhouse. The construction of this facility is expected to finish by February 2019.

The Evolve Marijuana ETF (SEED) invests 7.4% of its total portfolio in Cronos Group (CRON), 4.1% in Hexo Group (HEXO), and 6.6% in Aphria (APHA).

Latest articles

23 Jul

Will Fortinet Beat Q2 Earnings Estimates?

WRITTEN BY Aditya Raghunath

Leading cybersecurity company Fortinet (FTNT) is scheduled to announce its second-quarter earnings results on August 1. What should we expect?

Harley-Davidson’s Q2 earnings were slightly better than estimates.

Netflix (NFLX) has long relied on international markets to drive its streaming video business growth.

23 Jul

Could Ford’s Q2 Earnings Push Its Stock Even Higher?

WRITTEN BY Mohit Oberoi, CFA

Ford's second-quarter earnings results are scheduled for release on July 24. So far, Ford stock has outperformed its legacy peers.

23 Jul

Why RBC Isn't Optimistic about BlackBerry Stock

WRITTEN BY Aditya Raghunath

Shares of BlackBerry (BB) have been volatile over the last 12 months. BlackBerry stock fell 40.5% from $12.0 in September 2018 to $6.57 in December.

According to a Wall Street Journal report, Apple (AAPL) could be interested in buying Intel’s modem chip business.